Chinese vaccine is safe and effective, notes result published in The Lancet

0
3


Candidate was able to stimulate the production of antibodies in 600 patients, according to a respected specialized publication

An candidate vaccine developed by China based on a virus inactivated from SARS-CoV-2 (the name of new coronavirus) proved to be safe and able to stimulate the production of antibodies, according to the result of a preliminary test made public last Thursday, 15, in the specialized publication The Lancet Infectious Diseases journal.

The tests were carried out between April 29 and July 30 this year, with researchers from different Chinese institutions, including the Beijing Institute of Biological Products. They were submitted to 600 healthy patients aged between 18 and 80 years.

The study found stimulus to the production of antibodies in all patients in an interval of 42 days, without any adverse reaction.

Subscribe and have the best content of your day, perhaps the only one you need.

digital exam

R $ 15.90 / month

  • Access wherever and whenever you want.
  • Unlimited access to exclusive content on macroeconomics, markets, careers, entrepreneurship, technology and finance.

digital + printed exam

R $ 44.90 / month

  • Access wherever and whenever you want
  • Unlimited access to exclusive content on macroeconomics, markets, careers, entrepreneurship, technology and finance.
  • Biweekly print edition.
  • Free shipping

3981158

LEAVE A REPLY

Please enter your comment!
Please enter your name here